Valion Bio (VBIO) Shares Outstanding (2021 - 2026)

Valion Bio has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $135200.0 in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 249.93% year-over-year to $135200.0 in Q2 2026; TTM through Jun 2026 was $135200.0, a 249.93% increase from a year earlier, with the FY2025 full-year figure at $46221.0, up 302.1% from the prior year.
• Shares Outstanding (Entity) was $135200.0 for Q2 2026 at Valion Bio, up from $46221.0 in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $388609.0 in Q1 2022, with the low at $3871.0 in Q3 2022.
• Average Shares Outstanding (Entity) over 5 years is $97772.0, with a median of $46221.0 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) tumbled 97.93% in 2023, then jumped 1251.11% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $3871.0 in 2022, then surged by 719.48% to $31722.0 in 2023, then plunged by 63.76% to $11495.0 in 2024, then soared by 302.1% to $46221.0 in 2025, then soared by 192.51% to $135200.0 in 2026.
• The last three Shares Outstanding (Entity) figures came in at $135200.0 (Q2 2026), $46221.0 (Q4 2025), and $52831.0 (Q3 2025), per Business Quant data.